ID
37142
Beschreibung
Study ID: 104864/502 Clinical Study ID: 104864/502 Study Title: An Open-Label, Multicenter, Randomized, Phase II Study of Oral Topotecan Daily x 5 Days vs. Oral Topotecan 5 Days On, 2 Days Off for 3 Weeks for Second-Line Treatment in Patients with Recurrent, Locally Advanced or Metastatic Cervical Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: N/A Study Indication: Cancer, Locally Advanced or Metastatic Cervical Cancer
Stichworte
Versionen (1)
- 04.07.19 04.07.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
4. Juli 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Oral Topotecan Daily x 5 Days vs. Oral Topotacan 5 Days On, 2 Days Off; 104864/502
Post-Study Minimal Follow-Up Report
- StudyEvent: ODM
Beschreibung
Month of Report
Alias
- UMLS CUI-1
- C1704685
- UMLS CUI-2
- C0439231
Beschreibung
Follow-Up Report, Month
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Beschreibung
Follow-Up Report, Month
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Beschreibung
Outcome
Alias
- UMLS CUI-1
- C1547647
Beschreibung
Cessation of life
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0011065
Beschreibung
Date last contact
Datentyp
date
Alias
- UMLS CUI [1]
- C0805839
Beschreibung
Disease Progression
Datentyp
text
Alias
- UMLS CUI [1]
- C0242656
Beschreibung
Disease Progression, Start Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C0808070
Beschreibung
cancer treatment, post, Clinical Trials
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0032756
- UMLS CUI [1,3]
- C0008976
Beschreibung
cancer treatment, post, Clinical Trials, Start Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0032756
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [1,4]
- C0808070
Beschreibung
Form D
Alias
- UMLS CUI-1
- C0011065
Beschreibung
Cause of death
Datentyp
text
Alias
- UMLS CUI [1]
- C0007465
Beschreibung
Cause of death
Datentyp
text
Alias
- UMLS CUI [1]
- C0007465
Beschreibung
Date of death
Datentyp
date
Alias
- UMLS CUI [1]
- C1148348
Beschreibung
Autopsy
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0004398
Beschreibung
Autopsy, Finding, Diagnosis
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0004398
- UMLS CUI [1,2]
- C0243095
- UMLS CUI [1,3]
- C0011900
Beschreibung
I certify that I have reviewed the follow-up data and that all information is complete and accurate
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C2346576
Beschreibung
Cessation of life, Investigator Signature, Date in time
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C2346576
- UMLS CUI [1,3]
- C0011008
Ähnliche Modelle
Post-Study Minimal Follow-Up Report
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0032756 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0032756 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0243095 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C2346576 (UMLS CUI [1,2])
C2346576 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])